By April 12, 289,787 healthcare workers had been vaccinated in the first phase of SA’s Covid-19 vaccination programme, according to Mkhize.
US federal health agencies on Tuesday recommended pausing the J&J Covid-19 vaccine after six recipients developed a rare disorder involving blood clots. The move comes a week after European regulators said they had found a possible link between AstraZeneca's Covid-19 vaccine and a rare blood clotting problem that had led to a small number of deaths.
J&J's single-dose vaccine — most Covid-19 shots are delivered over two doses — and AstraZeneca's low-cost vaccine are seen as vital tools in the fight against a pandemic that has claimed more than three million lives.
“We have noted the decision taken by the Food & Drug Administration in the United States of America to advise the temporary suspension of the Johnson and Johnson vaccine rollout in the US,” said Mkhize.
“This has occurred due to reports of six females who developed unusual blood clots with low platelets. These incidents occurred between six and 13 days after vaccination in women between the ages of 18 and 48. It must be noted that over over 6.6 million citizens have been inoculated with the J&J vaccine in the US. In SA, we have not had any reports of clots that have formed after vaccination, and this is after having inoculated 289 787 healthcare workers under the Sisonke protocol,” he added.